Related Experiment Video
Updated: May 10, 2025

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic
Taimin Guo1, Yue Fu1, Xiaoyu Xu1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, China.
Ethambutol-associated optic neuropathy (EON) shows significant visual function recovery between 3 and 6 months. Early intervention, especially for patients with temporal peripapillary retinal nerve fiber layer thinning, is crucial for maximizing visual recovery potential.
Area of Science:
- Ophthalmology
- Neuroscience
Background:
- Ethambutol is a first-line treatment for tuberculosis.
- Ethambutol-associated optic neuropathy (EON) is a potential vision-threatening side effect.
- Understanding EON's temporal dynamics is crucial for patient management.
Purpose of the Study:
- To investigate the temporal evolution of visual function and optic nerve structure in EON.
- To identify factors influencing visual recovery and optic nerve changes in EON patients.
Main Methods:
- Retrospective observational study of 48 EON patients with 12-month follow-up.
- Comprehensive ophthalmologic assessments including BCVA, VF, OCT, and MRI.
- Statistical analyses including multiple linear regression and comparative tests to identify influencing factors.
Main Results:
- Significant improvements in BCVA and VF were observed between 3 and 6 months, indicating a critical recovery window.
- Peripapillary retinal nerve fiber layer (pRNFL) thinning was most pronounced between 3 and 9 months, with the temporal quadrant showing earliest changes.
- Disease course influenced VF recovery, while pRNFL thinning was associated with gender, ethambutol dosage, and disease duration; females showed slower pRNFL thinning.
Conclusions:
- A critical recovery window for visual function in EON exists between 3 and 6 months.
- Temporal pRNFL thinning may serve as an early marker for EON progression.
- Early therapeutic interventions are recommended for EON patients, particularly those with temporal RNFL thinning, to maximize visual recovery.

